Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,765.60
(
-1.52%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.88
(
7.18%
)
Bitcoin
71,323.92
(
-3.54%
)
News Focus
News Focus
Post# of 818445
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dennisdave

Send PM Follow Ignore
Followers 43
Posts 5340
Boards Moderated 0
Alias Born 12/05/2021

dennisdave

Re: Hopeforthefuture3 post# 730103

Monday, 11/04/2024 7:38:50 AM

Monday, November 04, 2024 7:38:50 AM

Post# of 818445
100% agree

First was the fda required it and second was crossover was needed to get people to join the trial as no one wants to be the control.


therefore I suspect the SurVaxM will have a lot of trouble finding patients willing to die so they can be compared with the treatment arm
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM

ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM

ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM

Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM

Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM

Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM

Start posting your company's news
Only $200 per official company press release!